medical reporting News
-
AVITA Medical Reports First Quarter 2022 Financial Results
AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today reported financial results for its first quarter ended March 31, 2022. Financial Highlights and Recent Updates: Reported commercial revenue, ...
-
Outset Medical to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, February 16, 2022
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full year of 2021 after the close of trading on Wednesday, February 16, 2022. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern ...
-
Moray Medical Featured in Medgadget Newsletter
Mark Barrish, CEO of Moray Medical, gave an interview to Medgadget, a well-known source for international medical technology news, health care trends, and medical research. Reporter Conn Hastings elicited clear, precise answers to questions ranging from the basics of heart valve failure to the advantages of augmented reality in Moray’s surgical ...
-
Outset Medical Reports Fourth Quarter and Full Year 2021 Financial Results
Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2021. The Company also announced that Leslie Trigg has been appointed Chair of the Board of Directors in ...
-
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that, effective May 23, 2022, its independent directors approved equity awards under Helius’ 2021 Inducement Plan, as a material inducement to four individuals entering into employment with the Company. The equity awards ...
-
Titan Medical Reports Financial Results for the First Quarter 2022
TORONTO--(BUSINESS WIRE)-- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three months ended March 31, 2022. “The entire team is focused on driving performance and progress supporting our IDE ...
-
Titan Medical Reports Voting Results From Annual and Special Meeting of Shareholders
TORONTO, June 09, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the voting results form the company’s Annual and Special Meeting of its shareholders held on Wednesday June 8, 2022. All of ...
-
enVVeno Medical Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Ended the quarter with $47.2 million in cash and investments – expected to fund operations through the end of 2024, including release of topline SAVVE pivotal trial data IRVINE, CA / August 3, 2022 / enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of venous disease, today provided a ...
-
Scivita Medical and the First Affiliated Hospital of Soochow University reached a cooperation intention for technical exchanges
Recently, a technical exchange meeting was held in the conference room of the park company Suzhou Scivita MedicalTechnology Co.. Ltd. Dean of the First Affiliated Hospital of Soochow University and a dozen directors and experts from various departments met with leaders and the elites of R&D and sales teams from Scivita Medical to discuss on cooperation project between hospital and industry. ...
-
enVVeno Medical Reports First Quarter 2022 Financial Results and Provides Corporate Update
Ended the quarter with $51.3 million in cash – expected to fund operations through the end of 2024 including release of topline pivotal trial data Ongoing advancement of SAVVE U.S pivotal trial with 20 sites available to enroll patients Progress on development of second device for the treatment of venous disease expected to be unveiled in mid-2022 IRVINE, CA / May 2, 2022 / enVVeno ...
-
IAQ Marketing Specialist Reveals his Personal Fight with Mold
A fungal infection caused by Coccidioides immitis, also known as Valley Fever, took its toll on Paul Cochrane, President of Cochrane & Associates, LLC. In the October 2010 issue of Indoor Environment Connections a personal story of one of the industry’s own is detailed in an article entitled, “A Fungal Infection of the Lungs”. The article details the story of the ...
-
‘South Asia’s canal projects spread malaria’, says report
Independent India should learn lessons from the deadly malaria epidemics that swept many parts of the country in the last century, attributable to indiscriminate canal building and related projects by the then rulers, a new study suggests. The study by Elizabeth Whitcombe, visiting senior research scholar at the earth system science interdisciplinary centre, University of Maryland, US, in the ...
By SciDev.Net
-
Liberate Medical Reports Positive Pilot Trial Results of VentFree Respiratory Muscle Stimulator
Applying non-invasive electrical stimulation to the expiratory abdominal muscles may reduce abdominal muscle atrophy and markedly reduce the number of days adult patients require mechanical ventilation – a potentially important finding for weaning ventilated patients, including seriously ill COVID-19 patients, and improving patient outcomes. Liberate Medical today announced the results of ...
-
enVVeno Medical Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
Ended the Year With $55 Million in Cash Expected To Fund Operations Through the End of 2024 Including Release of Topline Pivotal Trial Data Nine (9) VenoValve Surgeries Successfully Completed and 16 Clinical Sites Currently Active in Ongoing SAVVE U.S Pivotal Trial Continued Advancement in Development of Second Device for the Treatment of Venous Disease Expected To Be Unveiled in Mid-2022 ...
-
Why do you require to have a Liver transplant?
If anyhow, your liver stops working properly, you may need a liver transplant. Liver Transplant India is generally recommended if you have a last-stage liver disease, which is chronic liver failure. This is a life-threatening and serious liver disease, and this is be caused by many liver conditions. For instance, cirrhosis is one of the common causes of end-stage liver disease. It is one of the ...
-
ABK Biomedical partners with the CNIC to enhance patient care
ABK Biomedical, which is developing a transformative Eye90 microspheres® technology, with the potential to provide in-procedure prognostic dosimetry for cutting-edge treatment of liver tumours – has partnered with the Canadian Nuclear Isotope Council. The CNIC is an independent body made up of representatives from the Canadian health sector, nuclear industry and leading research ...
-
Adagio Medical Reports 85% Freedom from AF at 12 Months After a Single Ablation Procedure in Patients with Persistent Atrial Fibrillation and Presents Recent Developments of Pulsed Field Cryoablation Technology
Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), announced the results of its CryoCure-2 ultra-low temperature cryoablation (ULTC) prospective multi-center study in patients with AF at the 2021 Heart Rhythm Society Annual Meeting. The late-breaking clinical trials presentation was delivered by Dr. Tom De ...
-
Community-Acquired MRSA Infections on the Rise in the Mid-Atlantic
Methicillin-resistant Staphylococcus Aureus (MRSA) is a type of staph bacteria that is resistant to certain antibiotics known as beta-lactams. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin, and amoxicillin. In the community, most MRSA infections are skin infections. Last month, Time Magazine published a story about the rise of ...
-
Just say no to the glow!
Did you know that most conventional liquid laundry detergents contain an additive called optical brighteners? Seventh Generation, the nation's leading brand of environmentally responsible household and personal care products, has been formulating their detergents without these chemical additives and believes consumers, and the environment, will benefit as a result. "Optical brighteners are added ...
-
Esocap Featured In Fierce Pharma
“We are extremely pleased that Fierce Pharma Online reviewed EsoCap’s unique and innovative topical drug delivery system to the esophagus and the current Phase II program, as well as further use of its platform in additional indications,” said Isabelle Racamier, EsoCap AG CEO. “This strengthens our resolve to bring a major improvement to the lives of patients using ...
By EsoCap AG
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you